Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Lots of depth to Onc data needs to be understood

<< Previous

Bullboard Posts

Next >>

Comment by fasttrack5on Dec 19, 2021 2:25am

160 Views

Post# 34244323

RE:Lots of depth to Onc data needs to be understood

Couldn't agree more CF when there is blood on the street is a great time to add to one's position or if informed buy for ist time.
I believe we have seen some tax selling which has pushed the share value down.
that been said I have also added to my position whilst averaging down.
IMO and as you mentioned a number of analysts are betting on it.
just sayin Fast:)

<< Previous

Bullboard Posts

Next >>

WINNERS of the COP 29: Siemens Energy, Plug Power, dynaCERT!